Oppenheimer Asset Management Inc. lifted its position in athenahealth (NASDAQ:ATHN) by 2.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,652 shares of the health services provider’s stock after acquiring an additional 678 shares during the quarter. Oppenheimer Asset Management Inc. owned 0.08% of athenahealth worth $4,670,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of ATHN. Allianz Asset Management GmbH grew its position in shares of athenahealth by 67.0% in the 4th quarter. Allianz Asset Management GmbH now owns 555,766 shares of the health services provider’s stock worth $73,939,000 after acquiring an additional 223,006 shares in the last quarter. ARK Investment Management LLC grew its position in shares of athenahealth by 55.5% in the 4th quarter. ARK Investment Management LLC now owns 379,439 shares of the health services provider’s stock worth $50,481,000 after acquiring an additional 135,383 shares in the last quarter. Sumitomo Mitsui Asset Management Company LTD grew its position in shares of athenahealth by 40.3% in the 4th quarter. Sumitomo Mitsui Asset Management Company LTD now owns 454,160 shares of the health services provider’s stock worth $60,421,000 after acquiring an additional 130,545 shares in the last quarter. ArrowMark Colorado Holdings LLC grew its position in shares of athenahealth by 30.1% in the 4th quarter. ArrowMark Colorado Holdings LLC now owns 511,863 shares of the health services provider’s stock worth $68,098,000 after acquiring an additional 118,411 shares in the last quarter. Finally, Victory Capital Management Inc. acquired a new position in shares of athenahealth in the 1st quarter worth approximately $12,511,000.
Shares of athenahealth opened at $153.45 on Friday, MarketBeat reports. The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.71 and a current ratio of 2.71. The firm has a market cap of $6.21 billion, a price-to-earnings ratio of 97.74, a price-to-earnings-growth ratio of 2.85 and a beta of 1.16. athenahealth has a 1-year low of $111.61 and a 1-year high of $158.66.
athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, April 26th. The health services provider reported $1.25 earnings per share for the quarter, beating the consensus estimate of $0.72 by $0.53. The firm had revenue of $329.40 million for the quarter, compared to the consensus estimate of $318.13 million. athenahealth had a return on equity of 13.01% and a net margin of 6.77%. The firm’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.32 EPS. research analysts forecast that athenahealth will post 2.92 EPS for the current fiscal year.
Several research analysts have recently commented on the company. Deutsche Bank lifted their target price on athenahealth from $160.00 to $170.00 and gave the stock a “hold” rating in a research report on Tuesday. ValuEngine lowered athenahealth from a “buy” rating to a “hold” rating in a research report on Friday, May 18th. Jefferies Group set a $160.00 target price on athenahealth and gave the stock a “hold” rating in a research report on Thursday, May 17th. Royal Bank of Canada reissued a “hold” rating and issued a $160.00 price target on shares of athenahealth in a report on Thursday, May 17th. Finally, Berenberg Bank downgraded athenahealth from a “buy” rating to a “hold” rating and raised their price target for the stock from $143.00 to $163.00 in a report on Tuesday, May 15th. One equities research analyst has rated the stock with a sell rating, eighteen have issued a hold rating and eight have given a buy rating to the company. athenahealth currently has an average rating of “Hold” and a consensus price target of $152.64.
In other athenahealth news, CEO Jonathan Bush sold 4,750 shares of athenahealth stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $141.11, for a total transaction of $670,272.50. Following the sale, the chief executive officer now owns 320,557 shares of the company’s stock, valued at approximately $45,233,798.27. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jeffrey R. Immelt bought 3,600 shares of the business’s stock in a transaction on Tuesday, February 27th. The shares were acquired at an average cost of $141.04 per share, for a total transaction of $507,744.00. The disclosure for this purchase can be found here. Insiders have sold a total of 48,431 shares of company stock worth $7,084,565 in the last ninety days. 2.90% of the stock is owned by company insiders.
athenahealth Company Profile
athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.